stockrow
Friday 6 November 2026
Export IMVT’s income statement to Excel — free account
Immunovant, Inc.
IMVT Healthcare Biotechnology
- EPS
- −5.63%
- Free cash flow
- −5.96%
Quarter to June 2026, against a year earlier
30.53
2.14
+7.54%
Follow IMVT
Alert me
Immunovant, Inc. (IMVT) Net income
Immunovant, Inc.'s net income for fiscal 2026 was −$505.6M, compared with −$413.8M in fiscal 2025. Over the twelve months to 30 June 2026 it was −$538.2M. Over the past ten years it has ranged from −$505.6M (fiscal 2026) to −$400.00 (fiscal 2018) — the current reading is the lowest in ten years. Net income has fallen for 8 consecutive fiscal years. Immunovant, Inc. ranks 587th of 605 Biotechnology companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2026 | −$505.6M | — |
| FY2025 | −$413.8M | — |
| FY2024 | −$259.3M | — |
| FY2023 | −$211.0M | — |
| FY2022 | −$156.7M | — |
| FY2021 | −$107.4M | — |
| FY2020 | −$66.4M | — |
| FY2019 | −$28.6M | — |
| FY2018 | −$400.00 | — |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Jun 2026 | −$153.2M | — |
| Mar 2026 | −$147.9M | — |
| Dec 2025 | −$110.6M | — |
| Sep 2025 | −$126.5M | — |
| 27 more quarters | Free account |
Against its own ten years
Low −$505.6M
High −$400.00
Ten-year median
−$156.7M
Current reading's percentile
11
Net income against peers
| Company | Net income |
|---|---|
| LGND Ligand Pharmaceuticals Incorporated compare | $51.5M |
| BLTE Belite Bio, Inc. Sponsored ADR compare | −$77.6M |
| PTCT PTC Therapeutics, Inc. compare | −$106.0M |
| MANE Veradermics Incorporated compare | −$136.4M |
| CGON CG Oncology, Inc. compare | −$224.4M |
| KOD Kodiak Sciences Inc. compare | −$242.0M |
| IMVT Immunovant, Inc. | −$538.2M |
| IONS Ionis Pharmaceuticals, Inc. compare | −$565.2M |
| MIRM Mirum Pharmaceuticals, Inc. compare | −$903.9M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item